We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTG icon
1126
Entegris
ENTG
$16.6B
$278K ﹤0.01%
2,473
-1,191
-33% -$141K
EWBC icon
1127
East-West Bancorp
EWBC
$18B
$277K ﹤0.01%
3,344
-28
-0.8% -$2.25K
CSGP icon
1128
CoStar Group
CSGP
$12.1B
$276K ﹤0.01%
3,665
-1,560
-30% -$118K
FORM icon
1129
FormFactor
FORM
$6.45B
$276K ﹤0.01%
5,995
+415
+7% +$20.7K
MOS icon
1130
The Mosaic Company
MOS
$7.16B
$275K ﹤0.01%
10,271
+1,929
+23% +$53.1K
AEE icon
1131
Ameren
AEE
$30.8B
$275K ﹤0.01%
3,144
+34
+1% +$2.72K
FULT icon
1132
Fulton Financial
FULT
$4.69B
$274K ﹤0.01%
15,113
+2,387
+19% +$43.5K
GIB icon
1133
CGI
GIB
$15.6B
$273K ﹤0.01%
+2,377
New +$260K
PRG icon
1134
PROG Holdings
PRG
$1.67B
$273K ﹤0.01%
+5,632
New +$238K
CWT icon
1135
California Water Service
CWT
$3.11B
$273K ﹤0.01%
5,026
+390
+8% +$20.7K
WPM icon
1136
Wheaton Precious Metals
WPM
$48.7B
$272K ﹤0.01%
4,460
+79
+2% +$4.7K
IXN icon
1137
iShares Global Tech ETF
IXN
$7.94B
$272K ﹤0.01%
3,300
APTV icon
1138
Aptiv
APTV
$12.3B
$271K ﹤0.01%
3,764
-2,415
-39% -$169K
FMS icon
1139
Fresenius Medical Care
FMS
$13.3B
$271K ﹤0.01%
+12,722
New +$250K
ROCK icon
1140
Gibraltar Industries
ROCK
$1.3B
$268K ﹤0.01%
3,832
+778
+25% +$54.3K
VOOG icon
1141
Vanguard S&P 500 Growth ETF
VOOG
$24.9B
$268K ﹤0.01%
4,656
TER icon
1142
Teradyne
TER
$51.8B
$268K ﹤0.01%
1,998
+393
+24% +$53K
DAY
1143
DELISTED
Dayforce
DAY
$267K ﹤0.01%
4,363
+50
+1% +$2.75K
KURA icon
1144
Kura Oncology
KURA
$786M
$265K ﹤0.01%
13,577
+92
+0.7% +$1.86K
VPU
1145
Vanguard Utilities ETF
VPU
$8.62B
$264K ﹤0.01%
1,518
+152
+11% +$24.4K
EWC icon
1146
iShares MSCI Canada ETF
EWC
$6.12B
$264K ﹤0.01%
6,360
MGEE icon
1147
MGE Energy Inc
MGEE
$3.07B
$262K ﹤0.01%
+2,868
New +$245K
BBVA icon
1148
Banco Bilbao Vizcaya Argentaria
BBVA
$143B
$262K ﹤0.01%
24,138
+3,192
+15% +$33.2K
BBEU icon
1149
JPMorgan BetaBuilders Europe ETF
BBEU
$9.15B
$260K ﹤0.01%
4,174
BABA icon
1150
Alibaba
BABA
$276B
$260K ﹤0.01%
2,448
-498
-17% -$40.7K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.